3 completed. 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow MTZ: new trials by email Literature Review of MTZ trials Research Report on MTZ
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis Open flap debridement, Er: YAG irradiation, Metronidazole - Peri-Implantitis | Not applicable | Completed | University of Guarulhos | 89 | 2021-05-01 | 2024-07-18 |
| A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. ATM-AVI, MTZ, MER - Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia | Phase 3 | Completed | Pfizer | 422 | 2018-04-05 | 2024-12-10 |
| Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia Arsenic trioxide, Idarubicin, Cytarabine - Acute Promyelocytic Leukemia | Phase 3 | Completed | Technische Universität Dresden | 133 | 2016-06-01 | 2026-05-29 |
Leukemia, Promyelocytic, Acute (1) · Peri-Implantitis (1) · Pneumonia, Ventilator-Associated (1)
Pfizer (1) · Technische Universität Dresden (1) · University of Guarulhos (1)
Italy (2) · Spain (2) · Argentina (1) · Brazil (1) · Bulgaria (1) · China (1) · Croatia (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · India (1) · Israel (1) · Malaysia (1) · Mexico (1)
Jamil A Shibli, Professor (1) · Uwe Platzbecker, Prof. Dr. (1)
PMID 25039292, PMID 25494600, PMID 25867988, PMID 26285807, PMID 27013640, PMID 28303587, PMID 30422756, PMID 31261945, PMID 31576959, PMID 31994207, PMID 32844406, PMID 38252170, PMID 39389071, PMID 40530972, PMID 40825164, PMID 41269522
2017 (1)